Articles dans des revues avec comité de lecture (149)
58.
Hanotel, J., Bessodes, N., Thelie, A., Hedderich, M., Parain, K., Van Driessche, B., Brandão De Oliveira, K., Kricha, S., Jorgensen, M. C., Grapin-Botton, A., Serup, P., Van Lint, C., Perron, M., Pieler, T., Henningfeld, K. A., & Bellefroid, E. (2014). The Prdm13 histone methyltransferase encoding gene is a Ptf1a-Rbpj downstream target that suppresses glutamatergic and promotes GABAergic neuronal fate in the dorsal neural tube. Developmental biology, 386(2), 340-357. doi:10.1016/j.ydbio.2013.12.02459.
Eilebrecht, S., Le Douce, V., Roclet, R., Targat, B., Hallay, H., Van Driessche, B., Schwartz, C., Robette, G., Van Lint, C., Rohr, O., & Benecke, A. (2014). HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters. Nucleic acids research, 42(8), 4962-4971. doi:10.1093/nar/gku16861.
Cherrier, T., Le Douce, V., Eilebrecht, S., Riclet, R., Marban, C., Dequiedt, F., Goumon, Y., Paillart, J.-C., Mericskay, M., Parlakian, A., Bausero, P., Abbas, W., Herbein, G., Kurdistani, S., Grana, X., Van Driessche, B., Candolfi, E., Schwartz, C., Benecke, A., Van Lint, C., & Rohr, O. (2013). CTIP2 is a negative regulator of P-TEFb (*C. Van Lint and O. Rohr are co-last authors). Proceedings of the National Academy of Sciences of the United States of America, 110(31), doi: 10.1073/pnas.1220136110, 12655-60. doi:10.1073/pnas.122013611062.
Bouchat, S., Gatot, J.-S., Kabeya, K., Cardona, C., Colin, L., Herbein, G., De Wit, S., Clumeck, N., Lambotte, O., Rouzioux, C., Rohr, O., & Van Lint, C. (2012). Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients. AIDS, 26(12), 1473-1482. doi:10.1097/QAD.0b013e32835535f563.
The International AIDS Society Scientific Working Group on HIV Cure,, Deeks, S., Autran, B., Berkhout, B., Benkirane, M., Cairns, S., Chomont, N., Chun, T.-W., Churchill, M., Mascio, M. D., Katlama, C., Lafeuillade, A., Landay, A., Lederman, M., Lewin, S. R., Maldarelli, F., Margolis, D., Markowitz, M., Martinez-Picado, J., Mullins, J. I., Mellors, J., Moreno, S., O'Doherty, U., Palmer, S., Penicaud, M.-C., Peterlin, M., Poli, G., Routy, J.-P., Rouzioux, C., Silvestri, G., Stevenson, M., Telenti, A., Van Lint, C., Verdin, E., Woolfrey, A., Zaia, J., & Barré-Sinoussi, F. (2012). Towards an HIV cure: a global scientific strategy. Nature reviews. Immunology, 12(8), 607-614. doi:10.1038/nri326264.
Le Douce, V., Colin, L., Redel, L., Cherrier, T., Herbein, G., Aunis, D., Rohr, O., Van Lint, C., & Schwartz, C. (2012). LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing (O.Rohr, C. Van Lint and C. Schwartz are co-corresponding authors). Nucleic acids research, 40, 1904-1915. doi:10.1093/nar/gkr85765.
Simonis, N., Rual, J.-F., Lemmens, I., Boxus, M., Hirozane-Kishikawa, T., Gatot, J.-S., Dricot, A., Hao, T., Vertommen, D., Legros, S., Daakour, S., Klitgord, N., Martin, M., Willaert, J.-F., Dequiedt, F., Navratil, V., Cusick, M. E., Burny, A., Van Lint, C., Hill, D. E., Tavernier, J., Kettmann, R., Vidal, M., & Twizere, J.-C. (2012). Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology, 9, 26. doi:10.1186/1742-4690-9-2666.
Legros, S., Boxus, M., Gatot, J.-S., Van Lint, C., Kruys, V., Kettmann, R., Twizere, J.-C., & Dequiedt, F. (2011). The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6. Oncogene, 30(38), 4050-4062. doi:10.1038/onc.2011.12067.
Lens, Z., Dewitte, F., Van Lint, C., De Launoit, Y., Villeret, V., & Verger, A. (2011). Purification of SUMO-1 modified IκBα and complex formation with NF-κB. Protein expression and purification. doi:10.1016/j.pep.2011.06.00968.
Colin, L., Dekoninck, A., Reichert, M., Calao, M., Merimi, M., Van Den Broeke, A., Vierendeel, V., Cleuter, Y., Burny, A., Rohr, O., & Van Lint, C. (2011). Chromatin disruption in the promoter of Bovine Leukemia Virus during transcriptional activation. Nucleic acids research, 39, 9559-9573. doi:10.1093/nar/gkr671